{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:53:40Z","timestamp":1769205220505,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.clinthera.2009.11.018","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T04:59:17Z","timestamp":1264481957000},"page":"2565-2569","source":"Crossref","is-referenced-by-count":7,"title":["Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia"],"prefix":"10.1016","volume":"31","author":[{"given":"Elena","family":"Campione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Diluvio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelin J.","family":"Patern\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dely","family":"Di Marcantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Francesconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Terrinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.11.018_bib1","first-page":"715","article-title":"Gastrointestinal malignancy in patients with AIDS","volume":"86","author":"Danzig","year":"1991","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib2","first-page":"1251","article-title":"Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis","volume":"86","author":"Zinberg","year":"1991","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nm0795-707","article-title":"A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma","volume":"1","author":"Schalling","year":"1995","journal-title":"Nat Med."},{"key":"10.1016\/j.clinthera.2009.11.018_bib4","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science."},{"key":"10.1016\/j.clinthera.2009.11.018_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","article-title":"Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.clinthera.2009.11.018_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med."},{"key":"10.1016\/j.clinthera.2009.11.018_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2334-7-143","article-title":"Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections","volume":"7","author":"Giuliani","year":"2007","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.clinthera.2009.11.018_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/apc.2005.19.375","article-title":"Human herpesvirus-8 seropositivity and clinical correlations in HIV-1-positive and highly exposed, persistently HIV-seronegative individuals in Greece","volume":"19","author":"Panayiotakopoulos","year":"2005","journal-title":"AIDS Patient Care STDS."},{"key":"10.1016\/j.clinthera.2009.11.018_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.20090","article-title":"Kaposi's sarcoma: An update","volume":"87","author":"Schwartz","year":"2004","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib10","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/JVI.76.16.8383-8399.2002","article-title":"Kaposi's sarcomaassociated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells","volume":"76","author":"Moses","year":"2002","journal-title":"J Virol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib11","series-title":"Rook's Textbook of Dermatology","year":"2004"},{"key":"10.1016\/j.clinthera.2009.11.018_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-110-11-937","article-title":"Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS)","volume":"110","author":"Gill","year":"1989","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.clinthera.2009.11.018_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-8-7","article-title":"Pathology of rituximab-induced Kaposi sarcoma flare","volume":"8","author":"Pantanowitz","year":"2008","journal-title":"BMC Clin Pathol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib14","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial","volume":"25","author":"G\u00e9rard","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2005.06.079","article-title":"Imatinib-induced regression of AIDS-related Kaposi's sarcoma","volume":"23","author":"Koon","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/QAD.0b013e32826fb721","article-title":"Tumor markers and treatments for Kaposi sarcoma","volume":"21","author":"Anderson","year":"2007","journal-title":"AIDS."},{"key":"10.1016\/j.clinthera.2009.11.018_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2009.11.018_bib18","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukaemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.11.018_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajh.21096","article-title":"Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors","volume":"83","author":"Ou","year":"2008","journal-title":"Am J Hematol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib20","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1016\/j.febslet.2007.11.069","article-title":"Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells [published correction appears in FEBS Lett. 2008;582:398]","volume":"581","author":"Basciani","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clinthera.2009.11.018_bib21","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1200\/JCO.2003.99.170","article-title":"CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: Two case reports","volume":"21","author":"Abruzzese","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.clinthera.2009.11.018_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809004081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809004081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T14:51:26Z","timestamp":1544712686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809004081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0149291809004081"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.11.018","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}